Advertisement
Screener

HEALTHEQUITY, INC. (HQY) Spending and interest coverage

HEALTHEQUITY, INC. (HQY) Spending and interest coverage

  • R&D / revenue · 12 months: Value 20.41%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
  • Stock-based compensation / revenue · 12 months: Value 5.97%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months20.41%Research and development expense / revenue. Period ending 2026-07-31.

$277.96M ÷ $1.36B × 100 ≈ 20.41%

Stock-based compensation / revenue · 12 months5.97%Share-based compensation / revenue. Period ending 2026-07-31.

$81.28M ÷ $1.36B × 100 ≈ 5.97%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending277.96M USDResearch and Development Expense
Revenue1.36B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation81.28M USDShare-based Payment Arrangement, Noncash Expense
Operating income351.41M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-07-31$277.96M$1.36B$81.28M$351.41M(m)20.41%5.97%(m)(m)
2026-04-30$268.84M$1.34B$78.13M$342.33M(m)20.10%5.84%(m)(m)
2026-01-31$262.51M$1.31B$73.06M$322.46M(m)19.99%5.56%(m)(m)
2025-10-31$256.81M$1.29B$75.65M$293.54M(m)19.90%5.86%(m)(m)
2025-07-31$251.08M$1.27B$76.23M$234.47M(m)19.79%6.01%(m)(m)
2025-04-30$244.86M$1.24B$78.74M$203.78M(m)19.70%6.33%(m)(m)
2025-01-31$239.51M$1.20B$96.42M$162.33M(m)19.96%8.04%(m)(m)
2024-10-31$230.10M$1.15B$91.93M$159.07M(m)20.00%7.99%(m)(m)
2024-07-31$225.52M$1.10B$92.47M$170.34M(m)20.52%8.41%(m)(m)
2024-04-30$221.71M$1.04B$90.97M$136.15M$52.25M21.26%8.72%2.61×Reported
2024-01-31$218.81M$999.59M$77.15M$117.70M$55.45M21.89%7.72%2.12×Reported
2023-10-31$216.29M$971.04M$72.24M$92.03M$56.12M22.27%7.44%1.64×Reported
2023-07-31$209.57M$937.91M$68.75M$66.68M$54.74M22.34%7.33%1.22×Reported
2023-04-30$201.38M$900.50M$66.83M$39.53M$52.96M22.36%7.42%0.75×Reported
2023-01-31$193.38M$861.75M$62.61M$9.06M$48.42M22.44%7.27%0.19×Reported
2022-10-31$186.58M$831.20M$61.36M$-31.41M$44.87M22.45%7.38%-0.70×Reported
2022-07-31$175.76M$795.07M$56.47M$-37.32M$44.58M22.11%7.10%-0.84×Reported
2022-04-30$167.08M$778.03M$53.94M$-35.78M$40.34M21.47%6.93%-0.89×Reported
2022-01-31$157.36M$756.56M$52.75M$-24.24M$36.57M20.80%6.97%-0.66×Reported
2021-10-31$143.76M$741.43M$54.25M$1.43M$32.59M19.39%7.32%0.04×Reported
2021-07-31$136.44M$740.83M$52.45M$13.29M$27.67M18.42%7.08%0.48×Reported
2021-04-30$129.20M$727.76M$48.27M$23.20M$29.31M17.75%6.63%0.79×Reported
2021-01-31$124.81M$733.57M$42.86M$34.01M$34.88M17.01%5.84%0.98×Reported
2020-10-31$124.00M$746.60M$38.96M$50.14M$42.53M16.61%5.22%1.18×Reported
2020-07-31$116.76M$724.37M$45.06M$48.56M$45.80M16.12%6.22%1.06×Reported
2020-04-30$97.75M$634.95M$41.21M$64.40M$36.97M15.39%6.49%1.74×Reported
2020-01-31$77.58M$531.99M$39.84M$77.01M$24.77M14.58%7.49%3.11×Reported
2019-10-31$56.06M$406.57M$36.79M$79.05M(m)13.79%9.05%(m)(m)
2019-07-31$41.23M$319.95M$24.95M$88.11M(m)12.89%7.80%(m)(m)
2019-04-30$37.98M$304.39M$22.85M$84.81M(m)12.48%7.51%(m)(m)
2019-01-31$35.06M$287.24M$21.06M$77.67M(m)12.20%7.33%(m)(m)
2018-10-31$32.53M$271.90M$19.30M$69.52M(m)11.97%7.10%(m)(m)
2018-07-31$30.72M$258.20M$17.23M$64.10M(m)11.90%6.67%(m)(m)
2018-04-30$29.12M$244.01M$15.54M$59.03M(m)11.93%6.37%(m)(m)
2018-01-31$27.39M$229.53M$14.31M$54.42M(m)11.93%6.23%(m)(m)
2017-10-31$26.45M$215.90M$12.47M$52.16M(m)12.25%5.77%(m)(m)
2017-07-31$25.80M$202.47M$10.87M$47.65M(m)12.74%5.37%(m)(m)
2017-04-30$23.99M$189.78M$9.59M$43.89M(m)12.64%5.05%(m)(m)
2017-01-31$22.38M$178.37M$8.40M$41.21M(m)12.54%4.71%(m)(m)
2016-10-31$20.72M$167.44M$8.03M$39.39M(m)12.37%4.79%(m)(m)
2016-07-31$18.93M$154.64M$7.44M$36.65M(m)12.24%4.81%(m)(m)
2016-04-30$17.93M$140.95M$6.61M$31.41M(m)12.72%4.69%(m)(m)
2016-01-31$16.83M$126.79M$5.88M$26.14M(m)13.28%4.64%(m)(m)
2015-10-31$15.14M$115.77M$5.99M$23.80M(m)13.08%5.17%(m)(m)
2015-07-31$13.54M$107.08M$4.83M$21.79M(m)12.64%4.51%(m)(m)
2015-04-30$11.84M$97.47M$3.55M$19.37M(m)12.15%3.65%(m)(m)
2015-01-31$10.50M$87.86M$2.52M$16.87M$0.0011.95%2.87%(m)Reported
2014-10-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-07-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-04-30(m)$67.62M(m)(m)(m)(m)(m)(m)(m)
2014-01-31$7.14M$62.02M$57.00K$11.52M$44.00K11.52%0.09%261.91×Reported
2013-10-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-07-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-01-31$4.23M$46.09M$47.00K$7.09M$326.00K9.18%0.10%21.75×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ETSY INC (ETSY)United States$6.332B33.28
WEX Inc. (WEX)United States$6.321B13.79
Lyft, Inc. (LYFT)United States$5.580B1.93
Mobility Global Inc. (MBGL)United States$5.408B
ExlService Holdings, Inc. (EXLS)United States$5.373B18.52
Alight, Inc. / Delaware (ALIT)United States$5.053B
Amentum Holdings, Inc. (AMTM)United States$4.743B25.41
Maplebear Inc. (CART)United States$10.022B22.98
Xometry, Inc. (XMTR)United States$4.494B-10.08
Remitly Global, Inc. (RELY)United States$4.481B15.56